Delivery labor process Modalities Cases Controls OR 95%IC P
n  % n  %
Place of delivery UTH/P 22 34.9 68 54 1   0
At home 11 17.5 0 0 - -
On the way 3 4.8 0 0 - -
CSP 10 15.9 20 15.9 0.15 0.06-0.36
CSPP 17 27 38 30.2 1.38 0.65-2.90
Monitoring by labor curve No 35 55.6 27 21.4 1   0
Yes 28 44.4 99 78.6 0.21 0.1-0.4
Duration of labor (hours) Between 6 and 12 12 19 80 63.5 1   0
Lower than 6 6 9.5 8 6.3 5 1.5-16.9
Higher than 12 18 28.6 9 7.1 13.3 4.89-36.15
Non precise 27 42.9 29 23 - -
Nature of delivery Natural 35 57.4 102 81 1   0
AMTSL 14 23 4 3.2 10.2 3.07-33.05
Artificial 7 11.5 17 13.5 1,2 0.45-3.13
Directed 4 6.6 1 0.8 11,6 1.26-106.8
DMI 1 1.6 2 1.6 1.45 0.13-16.4
Monitoring inimmediatepostpartum No 25 39.7 3 2.4 1   0
Yes 38 60.3 123 97.6 0.03 0.008-0.10  
Medicated therapy during labor
Oxytocin No 34 50.8 64 54 1   0.681
Yes 29 49 .2 62 46 0.88 0.48-1.46
Antispasmodic No 57 80.2 101 90.5 1   0.071
Yes 6 19.8 27 9.5 0.39 0.15-0.99
Analgesic
(Trabar, HBB)
No 56 97.6 123 88.9 1   0.032
Yes 7 2.4 3 11.1 5.12 1.28-20.35
Prostaglandins non 62 100 126 98.4 1   0.333
Oui 1 0 0 1,6 0 -
Table 4: Distribution of risk factors of female patients who were victims of IPPH from May to August 2014 in the UTH/P according to delivery labor process
Goto home»